bromopyruvate has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Chen, F; Lai, J; Wang, H; Yuan, L | 1 |
| He, YY; Huang, KY; Jing, ZC; Shen, YF; Zhang, R; Zhang, YL; Zhao, JH | 1 |
2 other study(ies) available for bromopyruvate and Pulmonary Hypertension
| Article | Year |
|---|---|
3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
Topics: Animals; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Glycolysis; Hypertension, Pulmonary; Hypoxia; Male; Pyruvates; Rats; Rats, Sprague-Dawley | 2018 |
3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Topics: Animals; Apoptosis; Cardiac Catheterization; Disease Models, Animal; Enzyme Inhibitors; Glycolysis; Hypertension, Pulmonary; Immunohistochemistry; Male; Pulmonary Wedge Pressure; Pyruvates; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vascular Resistance | 2019 |